Related Experiment Video
Updated: May 25, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n
Michael J Coronado1, Jessica E Brandt, Eunyong Kim
1Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.
Insights
Testosterone exacerbates viral myocarditis in males by upregulating fibrotic genes like serpin A 3n, contributing to dilated cardiomyopathy (DCM) progression. This sex difference in cardiac remodeling is linked to hormonal influences.
Area of Science:
- Cardiovascular Research
- Immunology
- Genetics
Background:
- Myocarditis and dilated cardiomyopathy (DCM) affect men more than women, but the underlying reasons are unclear.
- Viral infections, such as coxsackievirus B3 (CVB3), are common causes of myocarditis and subsequent DCM.
Purpose of the Study:
- To investigate sex-based differences in cardiac gene expression during CVB3-induced myocarditis.
- To determine if testosterone influences cardiac remodeling and disease progression in male mice.
Main Methods:
- Comparison of CVB3 myocarditis and cardiac dilation severity between male and female BALB/c mice.
- Gene expression analysis of fibrotic remodeling and inflammatory markers.
- Gonadectomy and testosterone replacement experiments.
- In vivo assessment of serpin A 3n's role in cardiac fibrosis.
Main Results:
- Male mice exhibited more severe myocarditis and cardiac dilation than females, despite similar viral replication.
- Testosterone significantly upregulated cardiac TIMP-1, serpin A 3n, and MMP-8 in males.
- Testosterone increased cardiac IL-1β, which in turn upregulated serpin A 3n.
- Serpin A 3n was identified as a key gene altered during myocarditis, correlating with DCM in patients and mice.
- Exogenous serpin A 3n induced cardiac fibrosis during myocarditis.
Conclusions:
- Testosterone drives fibrotic gene expression, including serpin A 3n, in male hearts during viral myocarditis.
- Serpin A 3n is a critical mediator of cardiac fibrosis and progression to DCM in males.
- Hormonal factors contribute significantly to sex disparities in myocarditis and DCM outcomes.
Abstract:
Myocarditis and dilated cardiomyopathy (DCM) are often caused by viral infections and occur more frequently in men than in women, but the reasons for the sex difference remain unclear. The aim of this study was to assess whether gene changes in the heart during coxsackievirus B3 (CVB3) myocarditis in male and female BALB/c mice predicted worse DCM in males. Although myocarditis (P = 4.2 × 10(-5)) and cardiac dilation (P = 0.008) were worse in males, there was no difference in viral replication in the heart. Fibrotic remodeling genes, such as tissue inhibitor of metalloproteinase (TIMP)-1 and serpin A 3n, were upregulated in males during myocarditis rather than during DCM. Using gonadectomy and testosterone replacement, we showed that testosterone increased cardiac TIMP-1 (P = 0.04), serpin A 3n (P = 0.007), and matrix metalloproteinase (MMP)-8 (P = 0.04) during myocarditis. Testosterone increased IL-1β levels in the heart (P = 0.02), a cytokine known to regulate cardiovascular remodeling, and IL-1β in turn increased cardiac serpin A 3n mRNA (P = 0.005). We found that 39 of 118 (33%) genes identified in acute DCM patients were significantly altered in the heart during CVB3 myocarditis in mice, including serpin A 3n (3.3-fold change, P = 0.0001). Recombinant serpin A 3n treatment induced cardiac fibrosis during CVB3 myocarditis (P = 0.0008) while decreasing MMP-3 (P = 0.04) and MMP-9 (P = 0.03) levels in the heart. Thus, serpin A 3n was identified as a gene associated with fibrotic cardiac remodeling and progression to DCM in male myocarditis patients and mice.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Endocarditis III: Medical Management